6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione, 95.0%, 1g

3-BROMO-2-(TRIFLUOROMETHYL)BENZYL ALCHOL, 95.0%, 1g

2-Bromo-thiophene-3-carbaldehyde, 95.0%, 5g

Espátulas dobles, 5 Pieza(s)

2-Amino-4-chloro-6-hydroxy-5-nitropyrimidine, 95.0%, 5g

[S(R)]-N-[(S)-[3,5-Di-tert-butyl-4-methoxyphenyl][(3-benzyloxy-2-(dicyclohexylphosphino)phenyl)methyl]-N,2-dimethyl-2-propanesulfinamide, 95%, 100mg

4,7-dimethoxy-2-piperazin-1-yl-1,3-benzothiazole, 95.0%, 1g

Hexayodoplatinato(IV) de potasio 99,9% 1 g

1-(2-Aminoethyl)-4-benzyl piperazine, 96.0%, 1g

Acetato de 3-metoxi-3-metilbutilo, mínimo 98 %, para síntesis, 500 ml, envase de vidrio

[4-(methoxycarbonyl)-1H-pyrazol-1-yl]acetic acid, 100mg

BENZOFURAN-4-CARBALDEHYDE, 97.0%, 250mg

5-Bromo-2-chloro-N4-ethylpyridine-3,4-diamine, 98%, 1g